Project Grant R01NR020624
- Federal Project Grant Award Summary The National Cancer Institute (NCI) awarded $194,940 to the Icahn School of Medicine at Mount Sinai on August 6, 2025, under the Cancer Research Manpower program (CFDA 93.398) to support a career development initiative focused on early integrated primary and specialty palliative care for glioblastoma patients. This five-year project, extending through July 31, 2030, will generate knowledge regarding the feasibility and acceptability of a novel care model...
- Federal Grant Award Summary The National Institute on Aging (NIA) awarded The Trustees of Columbia University in the City of New York $713,283 under the Aging Research program (CFDA 93.866) for the project "Enhancing Palliative Care Integration in Home Healthcare: Assessing Readiness, Identifying Needs, and Overcoming Challenges" (EPIC-HHC). The award, issued February 15, 2026, with completion targeted for January 31, 2030, funds the development and deployment of home healthcare...
- Federal Project Grant Award Summary The National Institute of Nursing Research (NINR) awarded The Johns Hopkins University a $172,614 Project Grant effective March 4, 2026 through June 30, 2027 under the Nursing Research program (CFDA 93.361) to identify and measure palliative care needs among children with medical complexity in foster care. This exploratory mixed-methods study employs a participatory co-design approach to address the significant knowledge gap regarding unmet palliative needs in...
- The National Institute on Aging awarded a $145,043 Project Grant to the University of Colorado-Denver on September 3, 2025, under the Aging Research program (CFDA 93.866) to develop and validate an innovative palliative care screening tool for nursing home residents. The project, which extends through May 31, 2030, will deliver a resident-centered method to identify unmet palliative care needs among nursing home populations, with specific applicability for individuals with Alzheimer's disease...
- Federal Grant Award Summary The National Cancer Institute (NCI) awarded Massachusetts General Hospital a $1.72M Project Grant under the Cancer Cause and Prevention Research program (CFDA 93.393) effective June 1, 2025, through April 30, 2030. This award funds a randomized controlled trial of TARGET-PC, a five-session palliative care intervention designed to improve end-of-life (EOL) care outcomes for patients with metastatic breast cancer (MBC) and poor prognosis. The study will utilize the EPIC...
- This $2,307,536 federal Project Grant, awarded by the National Institute on Aging (CFDA 93.866 - Aging Research), will leverage a natural experiment to examine the effects of integrated palliative care on health service outcomes and disparities in Parkinson's disease and Lewy body dementia. The primary awardee, The Trustees of the University of Pennsylvania, will: Examine patterns of palliative domain care and disparities across U.S. Parkinson's specialty centers; and Test the effects of a...
- Federal Grant Award Summary The Medical University of South Carolina received a $711,060 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective August 20, 2025, with a completion date of August 31, 2027. The award funds the development and evaluation of "SUPPORT-T," a mobile application and digital health platform designed to increase access to palliative care for patients with...
- This Project Grant award of $422,500 from the National Institute on Aging under the Aging Research program (CFDA 93.866) supports a two-year research initiative at the Icahn School of Medicine at Mount Sinai, commencing September 1, 2025 through August 31, 2027. The funded research examines the drivers of high out-of-pocket spending (OOPS) among older adults with serious illness and the associated consequences on care quality and patient outcomes. The project specifically investigates how...
- This $761,403 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) will fund a randomized clinical trial of a "Longitudinal Transdisciplinary Neuropalliative Care Support" (LOTUS) team intervention for patients with severe stroke and their families. The LOTUS team, led by a specialized nurse, will provide in-person and telehealth support to enhance palliative care integration into stroke care across awareness, assistance, adjustment, acceptance, and...
- Federal Project Grant Award Summary The National Institute on Aging awarded Beth Israel Deaconess Medical Center $107,330 under the Aging Research program (CFDA 93.866) on August 15, 2025, with completion by April 30, 2027. This project grant supports research to establish a foundation for integrating treatment burden information into primary care for older adults with multiple chronic conditions (MCCs). The awardee will develop a scalable model to estimate treatment burden questionnaire (TBQ)...
TIER-Palliative Care Model Development and Implementation Icahn School of Medicine at Mount Sinai received a $755,540 Project Grant from the National Institute of Nursing Research (CFDA 93.361, Nursing Research program) awarded March 1, 2026, with completion targeted for December 31, 2030. The grant funds development and implementation of the TIER-Palliative Care (TIER-PC) model, an innovative population-based care delivery system designed to match evolving patient needs with appropriate palliative care services for community-based patients with heart failure or cancer. The TIER-PC model addresses workforce shortages in specialty palliative care by deploying clinicians strategically based on patient illness trajectory and changing clinical needs, ensuring efficient resource allocation across three care intensity levels. The deliverables include a scalable care model that provides tiered interventions calibrated to patient symptom severity and functional status. Tier 1 delivers community health worker (CHW) support trained in culturally competent illness communication for patients with manageable symptoms and maintained self-care capacity. Tier 2 integrates social work expertise in serious illness communication for patients with declining function and mild symptoms. Higher tiers add specialty-trained palliative care disciplines as symptoms worsen and functional decline accelerates. This adaptive model aims to improve symptom control, quality of life, goals-of-care communication, caregiver satisfaction, and reduce caregiver anxiety for vulnerable populations with two leading causes of death in the United States, while addressing documented access barriers to community-based specialty palliative care services.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $755.5k | 2/27/26 |